BridgeBio Pharma Q1 EPS $(0.84) Misses $(0.67) Estimate, Sales $194.515M Beat $177.937M Estimate
BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.67) by 25.37 percent. This is a 4.55 percent increase over losses of $(0.88) per share from
